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A B S T R A C T 
Fundamental importance of molecular genetic tests in solving clinical problems is outlined. Relations between 
genetic counseling and laboratory for molecular pathology in putting molecular genetic tests into practice are 
focused. Authors look at the possibilities for immediate application of DNA analysis according to the degree of 
exploration of different genes, determining monogenic diseases. Attention is paid to the methods for direct 
and indirect DNA analysis used postnatally and prenatally both for diagnosis and prevention. Definition of 
'informative' risk family is given, being an object for indirect methods of DNA analysis. Molecular genetic 
tests are shown as basis for research, genetic investigations of the populations and the diseases spread in them 
and for creating and applying mass and selective diagnostic and preventing screening programs that aim at 
ameliorating the human genome and decreasing the number of patients with socially significant hereditary 
diseases. 
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Molecular genetic tests have fundamental importance for 
investigating human genome and are widely applied in 
solving problems in clinical practice (1,2,5). Their popular-
ization is worth and perspective and this is the aim of the 
present paper. Nowadays, in Bulgaria molecular genetic 
tests are perfonned in the Laboratory for Molecular Pathol-
ogy in Sofia. Patients who need molecular genetic testing 
are counseled and evaluated by the geneticists working in 
the genetic counseling and referred to the Laboratory. 
At presence, scientific knowledge gives the chance DNA 
analysis to be done in the patients with some monogenic 
diseases presenting with typical clinical symptoms. These 
are the cases when the pathologic gene is charted, cloned 
and its heterogeneity is well investigated, for instance the 
CF gene (5). In other entities, like xxxxx DNA testing is 
possible only in families with more relatives presenting 
with the disease. When the pathologic gene is charted, but 
not well studied or gene coping exists, genetic material 
could be preserved in DNA bank (1,6) for the time when 
DNA testing becomes possible, as it happens with patients 
with Strumpel spastic paraparesis. 
In the patients with a certain monogenic disease DNA anal-
ysis could be performed and gene status easily determined 
in cases where the allelic variants in the population are few 
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or one or couple are most common. When there is a variety 
of the pathologic alleles and the frequency of each of them 
is very low, as it is with the haemophilic gene (5), finding 
the mutation/s/ in every concrete patient is a difficult task 
and sometimes it takes years to determine it. In the groups 
of entities with mutual coping of the phenotype caused by 
mutations in different gene loci, as, e. g., the sensory motor 
polyneuropathies (1,3,4,6,7), DNA testing is very compli-
cated. In these cases the alleles of the best known gene are 
specified and this is usually the gene causing the most com-
mon disease in the group. Genotype-phenotype correlation 
in the rest of the clinical fomis often remains important sci-
entific and practical problem. 
There are two approaches in performing DNA analysis. 
The first one is direct - mutation detection with the help of 
known DNA probes, and the second one is indirect - by fol-
lowing-up polymorphic DNA markers (1,5). The indirect 
analysis can be applied only to some families called "infor-
mative". In the informative families each of the parents' 
chromosomes could be exactly identified for its DNA 
structure in certain regions. These are the polymorphic 
markers, which are neutral mutations, i. e. not expressed in 
the phenotype. In the families that are not informative it is 
not possible to identify the chromosomes with the dis-
ease-causing mutation. The indirect DNA analysis is quite 
valuable for practical cases, but possible wrong interpreta-
tions must be minded being a result of crossing over, which 
has not changed markers' characteristics used for the analy-
sis. This risk is very actual for the huge genes like that of 
Duchene muscular dystrophy, but also exists when poly-
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morphic parts in a group of small neighbouring genes are 
used as markers, e. g., in [^-thalassemia. 
Molecular genetic tests are used for postnatal and prenatal 
analysis (1) that increases their significance for diagnostics 
and prevention and sometimes for the treatment of the he-
editary diseases. Molecular genetic research data give 
/iew to the allelic variety of genes and the frequency of the 
iifferent alleles in the population. They make their correla-
ion with specific clinical phenotype evident. Thus, specify-
ng the genotype of the patients, it could be possible to pre-
lict the degree of the clinical manifestation and prevent 
ome of the complications. Prevention could be done even 
arlier through applying mass and selective screening 
rogrammes (1), aiming at decreasing the number of cases 
f socially significant hereditary diseases. 
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